Formulation And Optimization Of Extended-Release Matrix Tablets Of Nateglinide
Adolescência e Saúde · 16.07.2026 · 21 (4s) · 776-785
DOI: 10.67440/ahj.v21i4s.1218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Adolescência e Saúde, online erschienen am 16.07.2026. Verfasst von Manoj Kumar Likhariya und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The present study focused on the formulation and optimization of extended-release matrix tablets of Nateglinide using natural polymers such as guar gum and xanthan gum. Tablets were prepared by direct compression and optimized using a Central Composite Design (CCD). The formulations were evaluated for post-compression parameters, swelling behavior, in-vitro drug release, and release kinetics. All batches showed acceptable physicochemical properties. Increased polymer concentration enhanced swelling and prolonged drug release due to the formation of a hydrophilic gel matrix. Among all formulations, F4 exhibited the best release profile with approximately 96% drug release over 12 hours. Drug release kinetics indicated predominantly Higuchi diffusion-controlled release, while the optimized formulation followed near zero-order kinetics with non-Fickian diffusion behavior. The study confirmed that the combination of guar gum and xanthan gum is suitable for developing extended-release matrix tablets of Nateglinide.
Zitieren
APA
Likhariya, M. K., Nagar, R., Jain, S. K., & Vengurlekar, S. (2026). Formulation And Optimization Of Extended-Release Matrix Tablets Of Nateglinide. Adolescência e Saúde, 21(4s), 776-785. https://doi.org/10.67440/ahj.v21i4s.1218
Vancouver
Likhariya MK, Nagar R, Jain SK, Vengurlekar S. Formulation And Optimization Of Extended-Release Matrix Tablets Of Nateglinide. Adolescência e Saúde. 2026;21(4s):776-785. doi:10.67440/ahj.v21i4s.1218
BibTeX
@article{Likhariya2026,
author = {Likhariya, Manoj Kumar and Nagar, Rajesh and Jain, Sachin Kumar and Vengurlekar, Sudha},
title = {Formulation And Optimization Of Extended-Release Matrix Tablets Of Nateglinide},
journal = {Adolescência e Saúde},
year = {2026},
volume = {21},
number = {4s},
pages = {776--785},
doi = {10.67440/ahj.v21i4s.1218}
}
EUVIMED